weight loss

A Victory Against False Advertising in Relacore Lawsuits

The N.J. Supreme Court gave a win to advocates of truth in advertising this week when it ruled that lawsuits against the maker of dietary supplement Relacore could go forward as a class action. Considering the way such lawsuits work, gaining that status is almost as important as the final verdict.

Vivus Hammered After FDA Panel's 'No' Vote

Pharmaceutical company Vivus is getting hammered in premarket trading, sinking more than 50% to around $5.32 in the wake of Thursday's vote by an FDA advisory panel against approving its weight-loss drug, Qnexa, based on safety concerns.

FDA Panel Rejects Weight-Loss Drug Qnexa

Pharmaceutical company Vivus and investors waited anxiously Thursday for the vote of an FDA advisory panel on the weight-loss drug Qnexa. The verdict is in, and by a vote of 9 to 7, panelists didn't support approving the drug as an obesity treatment.

Weight-Loss-Drug Maker Vivus Soars on FDA Review

An expert panel will review Vivus' potential blockbuster drug Qnexa on Thursday, with the FDA making a decision in October. The FDA acknowledges the drug's effectiveness in cutting weight, but it will certainly draw scrutiny over its side effects.

The Money Diet: a setback in week 6

I'm afraid to look at my bathroom scale. I have no idea if I've lost or gained weight this week. Well, actually, I have an idea, which is why I'd...